These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9022344)

  • 1. [Clinical application of gene technology for diagnosis and treatment of leukemia].
    Hashino S; Imamura M
    Rinsho Byori; 1997 Jan; 45(1):58-65. PubMed ID: 9022344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular diagnosis of leukemia and lymphoma].
    Iida S; Ueda R
    Rinsho Byori; 1994 Apr; 42(4):364-71. PubMed ID: 8176845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances in molecular cytogenetics of leukemia].
    Abe T
    Rinsho Ketsueki; 1993 Mar; 34(3):251-9. PubMed ID: 8479075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP; Young JH; Lin TH; Yang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular diagnosis in hematologic malignancies].
    Nara N
    Rinsho Byori; 2002 Apr; 50(4):331-6. PubMed ID: 12014009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The minimal residual disease (MRD) in hematological malignancies].
    Yokota S; Okamoto T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):762-8. PubMed ID: 11432342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Real-time PCR array for simultaneous detection of 37 kinds of fusion genes in leukemia].
    Liu HX; Zhu P; Zhang Y; Wang HX; DU JW; Liu J; Gu JY; Ou Y
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):526-32. PubMed ID: 17459201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia].
    Liu Q; Song L; Zhang Y; Wei Y; Xu D; Sun J; Liu X; Xu B; Meng F; Zhou S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):212-5. PubMed ID: 15793790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
    Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
    Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of molecular genetic investigations in the diagnosis of acute leukemias and in the detection of minimal residual disease].
    Földi J; Páldi HP; Nahajevszky S; Jakab K; Regéczi N; Pálóczi K
    Orv Hetil; 2001 May; 142(21):1097-102. PubMed ID: 11449838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in molecular biology of leukemias--clinical implications].
    Skórski T
    Acta Haematol Pol; 1995; 26(2 Suppl 1):14-8. PubMed ID: 7653230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene rearrangements in the molecular pathogenesis of acute promyelocytic leukemia.
    Kalantry S; Delva L; Gaboli M; Gandini D; Giorgio M; Hawe N; He LZ; Peruzzi D; Rivi R; Tribioli C; Wang ZG; Zhang H; Pandolfi PP
    J Cell Physiol; 1997 Nov; 173(2):288-96. PubMed ID: 9365539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells.
    Nason-Burchenal K; Takle G; Pace U; Flynn S; Allopenna J; Martin P; George ST; Goldberg AR; Dmitrovsky E
    Oncogene; 1998 Oct; 17(14):1759-68. PubMed ID: 9778041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi).
    Wilda M; Fuchs U; Wössmann W; Borkhardt A
    Oncogene; 2002 Aug; 21(37):5716-24. PubMed ID: 12173041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
    Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia: biology and treatment.
    Fenaux P; Chomienne C; Degos L
    Semin Oncol; 1997 Feb; 24(1):92-102. PubMed ID: 9045308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.